Bristol-Myers Squibb Company vs Altria Group, Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Bristol-Myers Squibb Company
$118.7B
μμ #149
Altria Group, Inc.
$121.4B
μμ #147
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Altria Group, Inc.μ΄(κ°) 2026λ κΉμ§ Bristol-Myers Squibb Companyμ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Bristol-Myers Squibb Company | Altria Group, Inc. | μ λ |
|---|---|---|---|
| 2026 | $118.7B | $121.4B | Altria Group, Inc. |
| 2025 | $107.8B | $93.0B | Bristol-Myers Squibb Company |
| 2024 | $107.6B | $78.6B | Bristol-Myers Squibb Company |
| 2023 | $92.9B | $55.6B | Bristol-Myers Squibb Company |
| 2022 | $125.8B | $57.9B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $55.6B | Bristol-Myers Squibb Company |
| 2020 | $102.0B | $44.7B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $50.0B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $46.3B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $64.1B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $58.5B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $48.6B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $39.4B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $29.2B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $22.7B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $20.3B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $15.9B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $11.9B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $8.4B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $12.4B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $10.1B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $8.5B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $6.6B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $5.6B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $3.9B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $4.2B | Bristol-Myers Squibb Company |
| 2000 | $54.6B | $3.8B | Bristol-Myers Squibb Company |
| 1999 | $46.6B | $1.9B | Bristol-Myers Squibb Company |
| 1998 | $48.0B | $4.1B | Bristol-Myers Squibb Company |
| 1997 | $33.4B | $3.4B | Bristol-Myers Squibb Company |
| 1996 | $18.8B | $2.7B | Bristol-Myers Squibb Company |
| 1995 | $14.3B | $2.1B | Bristol-Myers Squibb Company |
| 1994 | $9.2B | $1.3B | Bristol-Myers Squibb Company |